Sabra Healthcare REIT Inc (NASDAQ: SBRA) kicked off on Friday, up 1.73% from the previous trading day, before settling in for the closing price of $17.88. Over the past 52 weeks, SBRA has traded in a range of $13.81-$19.99.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Real Estate sector has jumped its sales by 3.39% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded 31.07%. With a float of $233.63 million, this company’s outstanding shares have now reached $237.94 million.
In an organization with 50 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 71.66%, operating margin of 51.53%, and the pretax margin is 19.59%.
Sabra Healthcare REIT Inc (SBRA) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the REIT – Healthcare Facilities Industry. The insider ownership of Sabra Healthcare REIT Inc is 1.81%, while institutional ownership is 99.03%. The most recent insider transaction that took place on Feb 24 ’25, was worth 23,880. In this transaction Director of this company bought 1,500 shares at a rate of $15.92, taking the stock ownership to the 60,583 shares. Before that another transaction happened on Feb 21 ’25, when Company’s Director bought 1,000 for $16.43, making the entire transaction worth $16,435. This insider now owns 59,083 shares in total.
Sabra Healthcare REIT Inc (SBRA) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 31.07% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 14.14% during the next five years compared to 7.91% growth over the previous five years of trading.
Sabra Healthcare REIT Inc (NASDAQ: SBRA) Trading Performance Indicators
Take a look at Sabra Healthcare REIT Inc’s (SBRA) current performance indicators. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.06. Likewise, its price to free cash flow for the trailing twelve months is 12.80.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.59, a number that is poised to hit 0.17 in the next quarter and is forecasted to reach 0.78 in one year’s time.
Technical Analysis of Sabra Healthcare REIT Inc (SBRA)
Let’s dig in a bit further. During the last 5-days, its volume was 3.13 million. That was better than the volume of 2.35 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 75.41%. Additionally, its Average True Range was 0.45.
During the past 100 days, Sabra Healthcare REIT Inc’s (SBRA) raw stochastic average was set at 93.35%, which indicates a significant increase from 86.14% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 22.57% in the past 14 days, which was lower than the 26.71% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $17.37, while its 200-day Moving Average is $17.48. However, in the short run, Sabra Healthcare REIT Inc’s stock first resistance to watch stands at $18.37. Second resistance stands at $18.54. The third major resistance level sits at $18.80. If the price goes on to break the first support level at $17.93, it is likely to go to the next support level at $17.67. Assuming the price breaks the second support level, the third support level stands at $17.50.
Sabra Healthcare REIT Inc (NASDAQ: SBRA) Key Stats
The company with the Market Capitalisation of 4.33 billion has total of 237,936K Shares Outstanding. Its annual sales at the moment are 703,240 K in contrast with the sum of 126,710 K annual income. Company’s last quarter sales were recorded 182,350 K and last quarter income was 46,700 K.
